<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="other">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">crystals</journal-id>
      <journal-title>Crystals</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Crystals</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Crystals</abbrev-journal-title>
      <issn pub-type="epub">2073-4352</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/cryst2041366</article-id>
      <article-id pub-id-type="publisher-id">crystals-02-01366</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A One-Dimensional Coordination Polymer Constructed from Cadmium(II) Cations and Sparfloxacinate Anions </article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>An</surname>
            <given-names>Zhe</given-names>
          </name>
          <xref rid="af1-crystals-02-01366" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gao</surname>
            <given-names>Jing</given-names>
          </name>
          <xref rid="af2-crystals-02-01366" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Harrison</surname>
            <given-names>William T. A.</given-names>
          </name>
          <xref rid="af3-crystals-02-01366" ref-type="aff">3</xref>
          <xref rid="c1-crystals-02-01366" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-crystals-02-01366"><label>1 </label>School of Chemistry and Life Science, Guangdong University of Petrochemical Technology, Maoming 525000, China; Email: <email>anzhe6409@sina.com</email></aff>
      <aff id="af2-crystals-02-01366"><label>2 </label>Department of Pharmacy, Mudanjiang Medical University, Heilongjiang 157011, China; Email: <email>gaojing_mmu@163.com</email></aff>
      <aff id="af3-crystals-02-01366"><label>3 </label>Department of Chemistry, University of Aberdeen, Meston Walk, Aberdeen AB24 3UE, UK</aff>
      <author-notes>
        <corresp id="c1-crystals-02-01366"><label>*</label> Author to whom correspondence should be addressed; Email: <email>w.harrison@abdn.ac.uk</email>; Tel.: +44-1224-272897; Fax: +44-1224-272921.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>28</day>
        <month>09</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>12</month>
        <year>2012</year>
      </pub-date>
      <volume>2</volume>
      <issue>4</issue>
      <fpage>1366</fpage>
      <lpage>1373</lpage>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>06</month>
          <year>2012</year>
        </date>
        <date date-type="rev-recd">
          <day>22</day>
          <month>08</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>01</day>
          <month>09</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2012 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <p>This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>The synthesis and crystal structure of the one-dimensional coordination polymer, [Cd(spar)<sub>2</sub>]<italic><sub>n</sub></italic>·<italic>n</italic>(H<sub>2</sub>O), are described, where spar<sup>−</sup> is the sparfloxacinate anion, C<sub>19</sub>H<sub>21</sub>N<sub>4</sub>O<sub>3</sub>F<sub>2</sub><sup>−</sup>. The Cd<sup>2+</sup> ion is bonded to four spar<sup>−</sup> ligands: Two O,O-chelate with their β-keto carboxylate groupings and two are monodentate-bound through a carboxylate O atom, to result in a distorted CdO<sub>6</sub> octahedral coordination geometry. The bridging ligands lead to [100] polymeric chains in the crystal and N–H···O hydrogen bonds and possible weak aromatic p–p stacking interactions help to consolidate the structure. Crystal data: C<sub>38</sub>H<sub>44</sub>CdF<sub>4</sub>N<sub>8</sub>O<sub>7</sub>, <italic>M</italic><sub>r</sub> = 913.21, triclinic, <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="crystals-02-01366-i001.tif"/> (No. 2), <italic>Z</italic> = 2, <italic>a</italic> = 9.2256(4) Å, <italic>b</italic> = 12.8767(5) Å, <italic>c</italic> = 17.4297(7) Å, <italic>α</italic> = 89.505(2)°, <italic>β</italic> = 85.062(2)°, <italic>γ</italic> = 70.757(2)°, <italic>V</italic> = 1947.20(14) Å<sup>3</sup>, <italic>R</italic>(<italic>F</italic>) = 0.036, <italic>wR</italic>(<italic>F</italic><sup>2</sup>) = 0.082.</p>
      </abstract>
      <kwd-group>
        <kwd>one-dimensional coordination polymer</kwd>
        <kwd>sparfloxacin</kwd>
        <kwd>cadmium </kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>1. Introduction</title>
      <p>Sparfloxacin (C<sub>19</sub>H<sub>22</sub>N<sub>4</sub>O<sub>3</sub>F<sub>2</sub>; Hspar; systematic name: 5-amino-1-cyclopropyl-7-[(3<italic>R</italic>*,5<italic>S</italic>*)(3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxo-quinoline-3-carboxylic acid), is a quinolone derivative (<xref ref-type="fig" rid="crystals-02-01366-f001">Figure 1</xref>) [<xref ref-type="bibr" rid="B1-crystals-02-01366">1</xref>] with significant antibiotic properties [<xref ref-type="bibr" rid="B2-crystals-02-01366">2</xref>,<xref ref-type="bibr" rid="B3-crystals-02-01366">3</xref>], although ironically, the effectiveness of Hspar and related compounds in treating infections appear to promote the subsequent colonization by “super bugs” such as MRSA [<xref ref-type="bibr" rid="B4-crystals-02-01366">4</xref>]. Our own interest in this class of compounds, along with that of others, is focused on their potential as multi-dentate and bridging ligands in the construction of new complexes [<xref ref-type="bibr" rid="B5-crystals-02-01366">5</xref>] and coordination polymers [<xref ref-type="bibr" rid="B6-crystals-02-01366">6</xref>,<xref ref-type="bibr" rid="B7-crystals-02-01366">7</xref>]. </p>
      <fig id="crystals-02-01366-f001" position="anchor">
        <label>Figure 1</label>
        <caption>
          <p>Chemical scheme for sparfloxacin (C<sub>19</sub>H<sub>22</sub>N<sub>4</sub>O<sub>3</sub>F<sub>2</sub>).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="crystals-02-01366-g001.tif"/>
      </fig>
      <p>The crystal structure of the hydrated, zwitterionic molecule of Hspar has been reported [<xref ref-type="bibr" rid="B8-crystals-02-01366">8</xref>] and its hydrate polymorphism demonstrated, which may have important pharmacological consequences [<xref ref-type="bibr" rid="B9-crystals-02-01366">9</xref>]. A molecular salt of the H<sub>2</sub>spar<sup>+</sup> cation with sulfate counter-ions is known [<xref ref-type="bibr" rid="B10-crystals-02-01366">10</xref>]. The crystal structures of its anionic complexes with nickel [<xref ref-type="bibr" rid="B11-crystals-02-01366">11</xref>], copper [<xref ref-type="bibr" rid="B12-crystals-02-01366">12</xref>,<xref ref-type="bibr" rid="B13-crystals-02-01366">13</xref>] and zinc [<xref ref-type="bibr" rid="B14-crystals-02-01366">14</xref>] have been reported. As an extension of these studies, we now describe the hydrothermal synthesis and crystal structure of the polymeric title compound, [Cd(spar)<sub>2</sub>]<italic><sub>n</sub></italic>·<italic>n</italic>(H<sub>2</sub>O), (<bold>1</bold>).</p>
    </sec>
    <sec sec-type="results">
      <title>2. Results and Discussion</title>
      <sec>
        <title>2.1. Crystal Structure of [Cd(spar)<sub>2</sub>]<italic><sub>n</sub>·n</italic>H<sub>2</sub>O (1)</title>
        <p>Compound <bold>1</bold> is a one-dimensional coordination polymer: The asymmetric unit contains a Cd<sup>2+</sup> cation, two mono-anionic spar<sup>−</sup> ligands and a disordered water molecule of crystallisation (<xref ref-type="fig" rid="crystals-02-01366-f002">Figure 2</xref>). </p>
        <p>The metal ion in <bold>1</bold> is coordinated by two bidentate spar<sup>−</sup> anions, with the ketone O-atom and its <italic>syn</italic>-carboxylate O atom (O3 and O2, respectively, in the C1-containing ion and O6 and O5, respectively, in the C20-ion) serving as the donors, which generates a six-membered chelate ring in each case. The metal coordination sphere is completed by two monodentate-O bonded spar<sup>−</sup> species: In each case the carboxylate O-atom anti to the ketone O-atom is involved. Together, these lead to a moderately distorted octahedral geometry for the CdO<sub>6</sub> polyhedron (<xref ref-type="table" rid="crystals-02-01366-t001">Table 1</xref>, <xref ref-type="fig" rid="crystals-02-01366-f003">Figure 3</xref>), with the monodentate O-atoms is a <italic>cis</italic> disposition. The mean Cd–O separation is 2.293 Å, the angular variance [<xref ref-type="bibr" rid="B15-crystals-02-01366">15</xref>] for the O–Cd–O bond angles is 105.2° and the bond-valence-sum (BVS) for the metal ion, calculated by the Brown–Altermatt formalism [<xref ref-type="bibr" rid="B16-crystals-02-01366">16</xref>], is 2.11 (expected value = 2.00). The –O2–C1–C2–C3–O3–Cd1– six-membered chelate ring approximates to a distorted half-chair, with O2 and Cd1 displaced by 0.320(5) Å and −0.702(7) Å, respectively, from the plane of the other four atoms (r.m.s. deviation = 0.026 Å). The –O5–C20–C21–C22–O6–Cd1– ring can be described in the same way, with O5 and Cd1 displaced by 0.190(5) Å and −1.013(7) Å, respectively, from the other atoms (r.m.s. deviation = 0.008 Å). The dihedral angle between the near-planar segments of the chelate rings is 32.0(3)°. </p>
        <fig id="crystals-02-01366-f002" position="anchor">
          <label>Figure 2</label>
          <caption>
            <p>The asymmetric unit of <bold>1</bold> (50% displacement ellipsoids), expanded to show the complete Cd<sup>2+</sup> coordination sphere. Hydrogen bonds are shown as double-dashed lines and the minor disorder components of the piperazine rings of the ligands and the disordered, uncoordinated water molecule are omitted for clarity. See <xref ref-type="table" rid="crystals-02-01366-t001">Table 1</xref> for symmetry codes.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="crystals-02-01366-g002.tif"/>
        </fig>
        <fig id="crystals-02-01366-f003" position="anchor">
          <label>Figure 3</label>
          <caption>
            <p>Detail of <bold>1</bold> showing the coordination geometry of the Cd<sup>2+</sup> ion (50% displacement ellipsoids for Cd and O). The octahedral edges are shown as open lines and the C atoms of the chelate rings are shown as spheres. See <xref ref-type="table" rid="crystals-02-01366-t001">Table 1</xref> for symmetry codes.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="crystals-02-01366-g003.tif"/>
        </fig>
        <table-wrap id="crystals-02-01366-t001" position="float">
          <object-id pub-id-type="pii">crystals-02-01366-t001_Table 1</object-id>
          <label>Table 1</label>
          <caption>
            <p>Selected geometrical data (Å,°) for <bold>1</bold>.</p>
          </caption>
          <table>
            <tbody>
              <tr>
                <td align="left" valign="middle">Cd1–O4</td>
                <td align="left" valign="middle">2.264(2)</td>
                <td align="left" valign="middle">Cd1–O1 <sup>i</sup></td>
                <td align="left" valign="middle">2.269(2)</td>
              </tr>
              <tr style="border-top: solid thin">
                <td align="left" valign="middle">Cd1–O5 <sup>ii</sup></td>
                <td align="left" valign="middle">2.280(2)</td>
                <td align="left" valign="middle">Cd1–O2</td>
                <td align="left" valign="middle">2.292(2)</td>
              </tr>
              <tr>
                <td align="left" valign="middle">Cd1–O6 <sup>ii</sup></td>
                <td align="left" valign="middle">2.304(2)</td>
                <td align="left" valign="middle">Cd1–O3</td>
                <td align="left" valign="middle">2.3466(19)</td>
              </tr>
              <tr>
                <td align="left" valign="middle"/>
                <td align="left" valign="middle"/>
                <td align="left" valign="middle"/>
                <td align="left" valign="middle"/>
              </tr>
              <tr>
                <td align="left" valign="middle">O4–Cd1–O1 <sup>i</sup></td>
                <td align="left" valign="middle">87.58(8)</td>
                <td align="left" valign="middle">O4–Cd1–O5 <sup>ii</sup></td>
                <td align="left" valign="middle">90.75(8)</td>
              </tr>
              <tr>
                <td align="left" valign="middle">O1 <sup>i</sup>–Cd1–O5 <sup>ii</sup></td>
                <td align="left" valign="middle">102.81(8)</td>
                <td align="left" valign="middle">O4–Cd1–O2</td>
                <td align="left" valign="middle">104.12(8)</td>
              </tr>
              <tr>
                <td align="left" valign="middle">O1 <sup>i</sup>–Cd1–O2</td>
                <td align="left" valign="middle">98.16(7)</td>
                <td align="left" valign="middle">O5 <sup>ii</sup>–Cd1–O2</td>
                <td align="left" valign="middle">154.76(7)</td>
              </tr>
              <tr>
                <td align="left" valign="middle">O4–Cd1–O6 <sup>ii</sup></td>
                <td align="left" valign="middle">164.30(7)</td>
                <td align="left" valign="middle">O1 <sup>i</sup>–Cd1–O6 <sup>ii</sup></td>
                <td align="left" valign="middle">100.15(8)</td>
              </tr>
              <tr>
                <td align="left" valign="middle">O5 <sup>ii</sup>–Cd1–O6 <sup>ii</sup></td>
                <td align="left" valign="middle">74.28(8)</td>
                <td align="left" valign="middle">O2–Cd1–O6 <sup>ii</sup></td>
                <td align="left" valign="middle">88.40(8)</td>
              </tr>
              <tr>
                <td align="left" valign="middle">O4–Cd1–O3</td>
                <td align="left" valign="middle">92.27(7)</td>
                <td align="left" valign="middle">O1 <sup>i</sup>–Cd1–O3</td>
                <td align="left" valign="middle">170.82(8)</td>
              </tr>
              <tr>
                <td align="left" valign="middle">O5 <sup>ii</sup>–Cd1–O3</td>
                <td align="left" valign="middle">86.37(7)</td>
                <td align="left" valign="middle">O2–Cd1–O3</td>
                <td align="left" valign="middle">72.97(7)</td>
              </tr>
              <tr>
                <td align="left" valign="middle">O6 <sup>ii</sup>–Cd1–O3</td>
                <td align="left" valign="middle">82.26(8)</td>
                <td align="left" valign="middle"> </td>
                <td align="left" valign="middle"> </td>
              </tr>
            </tbody>
          </table>
		  <table-wrap-foot>
		  <fn>
          <p>Symmetry codes: <sup>i</sup> 2 − <italic>x</italic>, 1 − <italic>y</italic>, 1 − <italic>z</italic>; <sup>ii</sup> 1 − <italic>x</italic>, 1 − <italic>y</italic>, 1 − <italic>z</italic>.</p>
		  </fn>
		  </table-wrap-foot>
        </table-wrap>
        <p>The important geometrical features of the first spar<sup>−</sup> anion (containing C1) are as follows: The C1–O1 and C1–O2 bond lengths of 1.266(4) Å and 1.250(3) Å, respectively, are typical for a delocalised carboxylate group and the dihedral angle between C1/O1/O2 and the adjacent N2-containing ring (r.m.s. deviation = 0.051 Å) is 11.5(5)°. The dihedral angle between the cyclopropane ring and the N2 ring is 66.4(2)°. The dihedral angle between the N2 ring and the C5 ring (r.m.s. deviation = 0.021 Å), which are fused at the C4–C9 bond, is 7.50(15)°, indicating a significant puckering to the quinolone system. The piperazine ring adopts a typical chair conformation with the N–C<sub>q</sub> (q = quinolone) bond in an equatorial orientation. Its geometry is complicated by disorder of the C atoms bearing the terminal methyl groups over two orientations, in a 0.766(10):0.234(10) ratio, but both of these maintain the (3<italic>R</italic>*,5<italic>S</italic>*) relative configurations of these stereogenic atoms. </p>
        <p>The second spar<sup>−</sup> anion (containing C20) has a broadly similar geometry: The C20–O4 and C20–O5 bond lengths are 1.273(3) Å and 1.250(3) Å, respectively, and the dihedral angle between C20/O4/O5 and the N6 ring (r.m.s. deviation = 0.037°) is 4.0(4)°. The dihedral angle between the N6 ring and the pendent three-membered ring is 73.5(2)°. The N6 and C24 rings (r.m.s. deviation for the latter = 0.041 Å), fused at the C23–C28 bond, are tilted by 4.38(16)°. The piperazine ring in the second anion shows the same type of positional disorder as the first, in a 0.908(8):0.092(8) ratio for the two orientations. </p>
        <p>The extended structure of <bold>1</bold> features polymeric chains in the [100] direction (<xref ref-type="fig" rid="crystals-02-01366-f004">Figure 4</xref>), such that each spar<sup>−</sup> anion links two cadmium metal ions. Adjacent metal ions are fused via eight-membered loops, generated by crystallographic inversion symmetry.</p>
        <fig id="crystals-02-01366-f004" position="anchor">
          <label>Figure 4</label>
          <caption>
            <p>Fragment of a [100] polymeric chain in <bold>1</bold> showing only the O atoms and linking C atoms of the ligands (50% displacement ellipsoids; symmetry codes as in <xref ref-type="table" rid="crystals-02-01366-t001">Table 1</xref>). The bonds of the C1 and C20 spar<sup>−</sup> anions are colored mint and plum, respectively. </p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="crystals-02-01366-g004.tif"/>
        </fig>
        <p>To complete the structure of <bold>1</bold>, several N–H···O hydrogen bonds occur of varying strengths, including a bifurcated N–H···(O,O) link (<xref ref-type="table" rid="crystals-02-01366-t002">Table 2</xref>). All of these bonds are intra-chain interactions. It is notable that neither of the piperazine H atoms (attached to N4 and N8) participates in a hydrogen bond, perhaps due in part to the steric crowding of the two adjacent methyl groups. Weak aromatic p–p stacking (centroid–centroid separation = 3.7164(17) Å between the N6 and C24 rings) might also play some role in consolidating the structure of <bold>1</bold>.</p>
        <table-wrap id="crystals-02-01366-t002" position="float">
          <object-id pub-id-type="pii">crystals-02-01366-t002_Table 2</object-id>
          <label>Table 2</label>
          <caption>
            <p>Hydrogen-Bond geometries for <bold>1</bold>.</p>
          </caption>
          <table>
  <tbody>
              <tr>
                <td align="left" valign="middle">N1–H1A···O1 <sup>iii</sup></td>
                <td align="center" valign="middle">0.86</td>
                <td align="center" valign="middle">2.33</td>
                <td align="center" valign="middle">3.021(3)</td>
                <td align="center" valign="middle">138</td>
              </tr>
              <tr style="border-top: solid thin">
                <td align="left" valign="middle">N1–H1B···O3</td>
                <td align="center" valign="middle">0.86</td>
                <td align="center" valign="middle">1.96</td>
                <td align="center" valign="middle">2.598(3)</td>
                <td align="center" valign="middle">130</td>
              </tr>
              <tr>
                <td align="left" valign="middle">N1–H1B···O5</td>
                <td align="center" valign="middle">0.86</td>
                <td align="center" valign="middle">2.35</td>
                <td align="center" valign="middle">3.061(3)</td>
                <td align="center" valign="middle">141</td>
              </tr>
              <tr>
                <td align="left" valign="middle">N5–H5A···O4 <sup>iii</sup></td>
                <td align="center" valign="middle">0.86</td>
                <td align="center" valign="middle">2.59</td>
                <td align="center" valign="middle">3.221(3)</td>
                <td align="center" valign="middle">131</td>
              </tr>
              <tr>
                <td align="left" valign="middle">N5–H5B···O6</td>
                <td align="center" valign="middle">0.86</td>
                <td align="center" valign="middle">1.98</td>
                <td align="center" valign="middle">2.609(3)</td>
                <td align="center" valign="middle">129</td>
              </tr>
  </tbody>
          </table>
		  <table-wrap-foot>
		  <fn>
          <p>The four columns specify the <italic>D</italic>–H, H···<italic>A</italic> and <italic>D</italic>···<italic>A</italic> separations (Å) and the <italic>D</italic>–H···<italic>A</italic> angle (°), respectively. Symmetry code: <sup>iii </sup><italic>x </italic><italic>−</italic> 1, <italic>y</italic>, <italic>z</italic>.</p>
		  </fn>
		  </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>2.2. Spectroscopy</title>
        <p>By analogy with data from related compounds [<xref ref-type="bibr" rid="B9-crystals-02-01366">9</xref>], the 1629 cm<sup>−1</sup> band is assigned as a C=O(pyridone) stretch and the 1570 cm<sup>−1</sup> and 1364 cm<sup>−1</sup> signals correspond to the carboxylate –CO<sub>2</sub> asymmetric and symmetric stretches, respectively.</p>
      </sec>
    </sec>
    <sec>
      <title>3. Experimental Section</title>
      <sec>
        <title>3.1. Synthesis and Characterization</title>
        <p>A mixture of cadmium acetate trihydrate (0.25 mmol), sparfloxacin (0.5 mmol), 1,4-benzenedicarboxylic acid (0.25 mmol), sodium hydroxide (1 mmol), and water (15 mL) was stirred for 30 min at room temperature. The mixture was then transferred to a 25-mL Teflon-lined reactor and heated to 423 K for 72 h under autogenous pressure. Upon cooling, colorless prisms of <bold>1</bold> were recovered from the reaction mixture by vacuum filtration. The role of the 1,4-benzenedicarboxylic acid in the synthesis is unknown, but it has not proved possible to prepare <bold>1</bold> if it is not present. </p>
        <p>Elemental analysis: calc (%) for C<sub>38</sub>H<sub>44</sub>CdF<sub>4</sub>N<sub>8</sub>O<sub>7</sub>: C 49.98, H 4.86, N 12.27; found (%): C 49.76, H 4.49, N 12.04. IR (cm<sup>−1</sup>, KBr): 3450 (br, m), 1629 (s), 1570 (s), 1449 (s), 1364 (w), 1290 (s). </p>
      </sec>
      <sec>
        <title>3.2. Single-Crystal Data Collection and Analysis</title>
        <p>The single-crystal data for <bold>1</bold> (colorless prism 0.20 × 0.20 × 0.18 mm) were collected using a Bruker APEX II CCD diffractometer (graphite monochromated MoK<italic>α</italic> radiation, <italic>λ</italic> = 0.71073 Å) at room temperature. Data reduction with SAINT [<xref ref-type="bibr" rid="B17-crystals-02-01366">17</xref>] then proceeded and the structure was solved by direct methods with SHELXS-97 [<xref ref-type="bibr" rid="B18-crystals-02-01366">18</xref>]. The resulting atomic model was developed and refined against |<italic>F</italic>|<sup>2</sup> with SHELXL-97 [<xref ref-type="bibr" rid="B18-crystals-02-01366">18</xref>] and the “observed data” threshold for calculating the <italic>R</italic>(<italic>F</italic>) residuals was set as <italic>I</italic> &gt; 2<italic>σ</italic>(<italic>I</italic>). The C-bound H atoms were placed in idealised locations (C–H = 0.93–0.98 Å) and refined as riding atoms. The N-bound H atoms were located in difference maps: Those attached to N1 and N5 were relocated to idealised locations (N–H = 0.86 Å) and refined as riding and those attached to N4 and N8 were refined as riding in their as-found relative locations. Due to the disorder of the piperazine rings, the location of the N4 and N8 H atoms are perhaps less certain, although they appeared reasonably distinctly in difference maps. The constraint <italic>U</italic><sub>iso</sub>(H) = 1.2<italic>U</italic><sub>eq</sub>(carrier) or 1.5<italic>U</italic><sub>eq</sub>(methyl carrier) was applied as appropriate. The H atoms associated with the disordered water molecule could not be located; based on geometrical considerations, one of the water molecules may form a hydrogen bond to N4. The structural model was analysed and validated with PLATON [<xref ref-type="bibr" rid="B19-crystals-02-01366">19</xref>] and full refinement details are given in the deposited cif. </p>
        <p>Crystal data for <bold>1</bold>: C<sub>38</sub>H<sub>44</sub>CdF<sub>4</sub>N<sub>8</sub>O<sub>7</sub>, <italic>M</italic><sub>r</sub> = 913.21, triclinic, <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="crystals-02-01366-i001.tif"/> (No. 2), <italic>Z</italic> = 2, <italic>a</italic> = 9.2256(4) Å, <italic>b</italic> = 12.8767(5) Å, <italic>c</italic> = 17.4297(7) Å, <italic>α</italic> = 89.505(2)°, <italic>β</italic> = 85.062(2)°, <italic>γ</italic> = 70.757(2)°, <italic>V</italic> = 1947.20(14) Å<sup>3</sup>, <italic>F</italic>(000) = 936, <italic>T</italic> = 296(2) K, <italic>ρ</italic><sub>calc</sub> = 1.558 g·cm<sup>−3</sup>, <italic>μ</italic> = 0.640 mm<sup>−1</sup>, 27884 reflections recorded (3.4° ≤ 2<italic>θ</italic> ≤ 50.0°; −10 ≤ <italic>h</italic> ≤ 10, −15 ≤ <italic>k</italic> ≤ 15, −20 ≤ <italic>l</italic> ≤ 20), <italic>R</italic><sub>Int</sub> = 0.039, 6848 merged reflections, 6225 with <italic>I</italic> &gt; 2<italic>σ</italic>(<italic>I</italic>), 541 variable parameters, <italic>R</italic>(<italic>F</italic>) = 0.036, <italic>wR</italic>(<italic>F</italic><sup>2</sup>) = 0.082, min./max. ∆<italic>ρ</italic> = −0.58/0.46 <italic>e</italic> Å<sup>−3</sup>. Cambridge Structural Database deposition number: CCDC-888200.</p>
      </sec>
    </sec>
    <sec sec-type="conclusions">
      <title>4. Conclusions</title>
      <p>The synthesis and crystal structure of the title one-dimensional coordination polymer have been described, in which the metal atom adopts a distorted octahedral geometry arising from its coordination by two O,O-bidentate and two O-monodentate spar<sup>−</sup> anions. The linkages in the polymeric chain are centrosymmetric eight-membered rings. The structure of <bold>1</bold> is completely different to that of Cd<sub>2</sub>(enro)<sub>4</sub>(H<sub>2</sub>O)<sub>2</sub>·4H<sub>2</sub>O (Henro = enroflaxacin; C<sub>19</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub>F), in which isolated binuclear complexes occur and the metal coordination geometry is a CdO<sub>6</sub> trigonal prism [<xref ref-type="bibr" rid="B5-crystals-02-01366">5</xref>]. In [Cd(cipro)<sub>2</sub>]<italic><sub>n</sub></italic>·2.5<italic>n</italic>H<sub>2</sub>O (Hcipro = ciprofloxacin; C<sub>17</sub>H<sub>18</sub>FN<sub>3</sub>O<sub>4</sub>) [<xref ref-type="bibr" rid="B6-crystals-02-01366">6</xref>], the Cd<sup>2+</sup> ion is coordinated by O,O-bidentate and N<sub>p</sub>-bonded (p = piperazine) cipro<sup>−</sup> ions to generate a coordination network containing <italic>trans</italic>-CdN<sub>2</sub>O<sub>4</sub> octahedra. Conversely, Cd(Hcipro)<sub>2</sub>Cl<sub>2</sub>·4H<sub>2</sub>O is a mononuclear complex containing O,O-bidentate neutral, zwitterionic Hcipro molecules and two charge-balancing chloride ions to generate <italic>trans</italic>-CdCl<sub>2</sub>O<sub>4</sub> octahedra [<xref ref-type="bibr" rid="B20-crystals-02-01366">20</xref>].</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="B1-crystals-02-01366">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andersson</surname>
              <given-names>M.I.</given-names>
            </name>
            <name>
              <surname>MacGowan</surname>
              <given-names>A.P.</given-names>
            </name>
          </person-group>
          <article-title>Development of the quniolones</article-title>
          <source>J. Antimicrob. Chemother.</source>
          <year>2003</year>
          <volume>51</volume>
          <fpage>1</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="doi">10.1093/jac/dkg212</pub-id>
        </citation>
      </ref>
      <ref id="B2-crystals-02-01366">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miyamoto</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>J.-I.</given-names>
            </name>
            <name>
              <surname>Chiba</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Egawa</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Shibamori</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Minamida</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Nishimura</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Okada</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kataoka</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Fujita</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hirose</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Nakano</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Pyridonecarboxylic acids as antibacterial agents. 14: Synthesis and structure-activity relationship of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinoline antibacterial agent with improved potency</article-title>
          <source>J. Med. Chem.</source>
          <year>1990</year>
          <volume>33</volume>
          <fpage>1645</fpage>
          <lpage>1656</lpage>
          <pub-id pub-id-type="doi">10.1021/jm00168a018</pub-id>
        </citation>
      </ref>
      <ref id="B3-crystals-02-01366">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qadri</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Ueno</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Burns</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Almodovar</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Rabea</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title><italic>In vitro</italic> activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone</article-title>
          <source>Chemotherapy</source>
          <year>1992</year>
          <volume>38</volume>
          <fpage>99</fpage>
          <lpage>106</lpage>
          <pub-id pub-id-type="doi">10.1159/000238948</pub-id>
        </citation>
      </ref>
      <ref id="B4-crystals-02-01366">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tacconelli</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>De Angelis</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Cataldo</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Pozzi</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Cauda</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Does antibiotic exposure increase the risk of methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) isolation? A systematic review and meta-analysis</article-title>
          <source>J. Antimicrob. Chemother.</source>
          <year>2007</year>
          <volume>61</volume>
          <fpage>26</fpage>
          <lpage>38</lpage>
          <pub-id pub-id-type="doi">10.1093/jac/dkm416</pub-id>
        </citation>
      </ref>
      <ref id="B5-crystals-02-01366">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>An</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>W.T.A.</given-names>
            </name>
          </person-group>
          <article-title>Two binuclear complexes containing the enrofloxacinate anion: Cd<sub>2</sub>(C<sub>19</sub>H<sub>21</sub>N<sub>3</sub>O<sub>3</sub>F)<sub>4</sub>(H<sub>2</sub>O)<sub>2</sub>·4H<sub>2</sub>O and Pb<sub>2</sub>(C<sub>19</sub>H<sub>21</sub>N<sub>3</sub>O<sub>3</sub>F)<sub>4</sub>·4H<sub>2</sub>O</article-title>
          <source>J. Coord. Chem.</source>
          <year>2010</year>
          <volume>63</volume>
          <fpage>3871</fpage>
          <lpage>3879</lpage>
          <pub-id pub-id-type="doi">10.1080/00958972.2010.524699</pub-id>
        </citation>
      </ref>
      <ref id="B6-crystals-02-01366">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xiao</surname>
              <given-names>D.-R.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>E.-B.</given-names>
            </name>
            <name>
              <surname>An</surname>
              <given-names>H.-Y.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>Z.-M.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y.-G.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>C.-Y.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Rationally designed, polymeric, extended metal-ciprofloxacin complexes</article-title>
          <source>Chem. Eur. J.</source>
          <year>2005</year>
          <volume>11</volume>
          <fpage>6673</fpage>
          <lpage>6686</lpage>
          <pub-id pub-id-type="doi">10.1002/chem.200500548</pub-id>
        </citation>
      </ref>
      <ref id="B7-crystals-02-01366">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>An</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>L.-R.</given-names>
            </name>
          </person-group>
          <article-title>Poly[bis[μ-1-cyclopropyl-6-fluoro-4-oxido-7-(1-piperazinyl)-1,4-dihydroquinoline-3-carboxylato]nickel(II)]</article-title>
          <source>Acta Cryst.</source>
          <year>2008</year>
          <volume>E64</volume>
          <fpage>m176</fpage>
        </citation>
      </ref>
      <ref id="B8-crystals-02-01366">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sivalakshmidevi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Vyas</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Om Reddy</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Sparfloxacin, an antibacterial drug</article-title>
          <source>Acta Cryst.</source>
          <year>2000</year>
          <volume>C56</volume>
          <fpage>e115</fpage>
          <lpage>e116</lpage>
        </citation>
      </ref>
      <ref id="B9-crystals-02-01366">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Llinas</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Burley</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Prior</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Glen</surname>
              <given-names>R.C.</given-names>
            </name>
            <name>
              <surname>Goodman</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>Concomitant hydrate polymorphism in the precipitation of sparfloxacin from aqueous solution</article-title>
          <source>Cryst. Growth Des.</source>
          <year>2008</year>
          <volume>8</volume>
          <fpage>114</fpage>
          <lpage>118</lpage>
          <pub-id pub-id-type="doi">10.1021/cg700908m</pub-id>
        </citation>
      </ref>
      <ref id="B10-crystals-02-01366">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.C.</given-names>
            </name>
            <name>
              <surname>Lian</surname>
              <given-names>Q.</given-names>
            </name>
          </person-group>
          <article-title>Bis[(2<italic>R</italic>,6<italic>S</italic>)-4-(5-amino-3-carboxy-1-cyclopropyl-6,8-difluoro-4-oxo-1,4-dihydroquinolin-7-yl)-2,6-dimethylpiperazin-1-ium] sulfate pentahydrate</article-title>
          <source>Acta Cryst.</source>
          <year>2011</year>
          <volume>E67</volume>
          <fpage>o3366</fpage>
        </citation>
      </ref>
      <ref id="B11-crystals-02-01366">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Skyrianou</surname>
              <given-names>K.C.</given-names>
            </name>
            <name>
              <surname>Raptopoulou</surname>
              <given-names>C.P.</given-names>
            </name>
            <name>
              <surname>Psycharis</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Kessissoglou</surname>
              <given-names>D.P.</given-names>
            </name>
            <name>
              <surname>Psomas</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Structure, cyclic voltammetry and DNA-binding properties of the bis(pyridine)bis(sparfloxacinato)nickel(II) complex</article-title>
          <source>Polyhedron</source>
          <year>2009</year>
          <volume>28</volume>
          <fpage>3265</fpage>
          <lpage>3271</lpage>
          <pub-id pub-id-type="doi">10.1016/j.poly.2009.04.002</pub-id>
        </citation>
      </ref>
      <ref id="B12-crystals-02-01366">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Efthimiadou</surname>
              <given-names>E.K.</given-names>
            </name>
            <name>
              <surname>Sanakis</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Raptopoulou</surname>
              <given-names>C.P.</given-names>
            </name>
            <name>
              <surname>Karaliota</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Katsaros</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Psomas</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Crystal structure, spectroscopic, and biological study of the copper(II) complex with third-generation quinolone antibiotic sparfloxacin</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2006</year>
          <volume>16</volume>
          <fpage>3864</fpage>
          <lpage>3867</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2006.04.034</pub-id>
        </citation>
      </ref>
      <ref id="B13-crystals-02-01366">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shingnapurkar</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Butcher</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Afrasiabi</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Sinn</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Ahmed</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Sarkar</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Padhye</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Neutral dimeric copper-sparfloxacin conjugate having butterfly motif with antiproliferative effects against hormone independent BT20 breast cancer cell line</article-title>
          <source>Inorg. Chem. Commun.</source>
          <year>2007</year>
          <volume>10</volume>
          <fpage>459</fpage>
          <lpage>462</lpage>
          <pub-id pub-id-type="doi">10.1016/j.inoche.2006.12.016</pub-id>
        </citation>
      </ref>
      <ref id="B14-crystals-02-01366">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tarushi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Polatoglou</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Kljun</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Turel</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Psomas</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Kessissoglou</surname>
              <given-names>D.P.</given-names>
            </name>
          </person-group>
          <article-title>Interaction of Zn(II) with quinolone drugs: Structure and biological evaluation</article-title>
          <source>Dalton Trans.</source>
          <year>2011</year>
          <volume>40</volume>
          <fpage>9461</fpage>
          <lpage>9473</lpage>
          <pub-id pub-id-type="doi">10.1039/c1dt10870k</pub-id>
        </citation>
      </ref>
      <ref id="B15-crystals-02-01366">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robinson</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Gibbs</surname>
              <given-names>G.V.</given-names>
            </name>
            <name>
              <surname>Ribbe</surname>
              <given-names>P.H.</given-names>
            </name>
          </person-group>
          <article-title>Quadratic elongation–quantitative measure of distortion in coordination polyhedra</article-title>
          <source>Science</source>
          <year>1971</year>
          <volume>172</volume>
          <fpage>567</fpage>
          <lpage>570</lpage>
        <pub-id pub-id-type="doi">10.1126/science.172.3983.567</pub-id><pub-id pub-id-type="pmid">17802221</pub-id></citation>
      </ref>
      <ref id="B16-crystals-02-01366">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>I.D.</given-names>
            </name>
            <name>
              <surname>Altermatt</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Bond-Valence parameters obtained from a systematic analysis of the Inorganic Crystal Structure Database</article-title>
          <source>Acta Cryst.</source>
          <year>1985</year>
          <volume>B41</volume>
          <fpage>244</fpage>
          <lpage>247</lpage>
        </citation>
      </ref>
      <ref id="B17-crystals-02-01366">
        <label>17.</label>
        <citation citation-type="book">
          <source>APEX2 and SAINT Diffractometer Control Software</source>
          <publisher-name>Bruker AXS Inc.</publisher-name>
          <publisher-loc>Madison, WI, USA</publisher-loc>
          <year>2009</year>
        </citation>
      </ref>
      <ref id="B18-crystals-02-01366">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sheldrick</surname>
              <given-names>G.M.</given-names>
            </name>
          </person-group>
          <article-title>A short history of SHELX</article-title>
          <source>Acta Cryst.</source>
          <year>2008</year>
          <volume>A64</volume>
          <fpage>112</fpage>
          <lpage>122</lpage>
        </citation>
      </ref>
      <ref id="B19-crystals-02-01366">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spek</surname>
              <given-names>A.L.</given-names>
            </name>
          </person-group>
          <article-title>Structure validation in chemical crystallography</article-title>
          <source>Acta Cryst.</source>
          <year>2009</year>
          <volume>D65</volume>
          <fpage>148</fpage>
          <lpage>155</lpage>
        </citation>
      </ref>
      <ref id="B20-crystals-02-01366">
        <label>20.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lopez-Gresa</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Ortiz</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Perello</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Latorre</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Liu-Gonzalez</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Garcia-Granda</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Perez-Priede</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Canton</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Interactions of metal ions with two quinolone antimicrobial agents (cinoxacin and ciprofloxacin)—Spectroscopic and X-ray structural characterization. Antibacterial studies</article-title>
          <source>J. Inorg. Biochem.</source>
          <year>2002</year>
          <volume>92</volume>
          <fpage>65</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="doi">10.1016/S0162-0134(02)00487-7</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
